Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 12, 2010 | TME Pharma | $2.8M Series D Extension | — | Sofinnova Partners, CD-Venture, DEWB, IBB Ventures, IBG Sachsen-Anhalt, NGN Capital, Oppenheim Asset Management Services, Seventure Partners, The Dow Chemical Company, TVM Capital |
| May 1, 2010 | TME Pharma | $41.0M Series D | NGN Capital | Andera Partners, FCP OP MEDICAL BioHealth-Trends, IBB Ventures, IBG Sachsen-Anhalt, Seventure Partners, Sofinnova Partners, The Dow Chemical Company, TVM Capital |